Brickell Biotech Inc BBI:NASDAQ

Last Price$0.21Cboe Closing Price as of 3:59PM ET 1/27/22
Cboe Real-Time Quotes
Today's Change-0.01(4.43%)
Bid (Size)$0.20 (300)
Ask (Size)$0.35 (100)
Day Low / High$0.20 - 0.22
Volume3.9 M

View Pharmaceuticals: Major IndustryPeer Comparison as of 01/27/2022


Brickell Biotech Inc ( NASDAQ )

Price: $0.21
Change: -0.01 (4.43%)
Volume: 3.9 M
3:59PM ET 1/27/2022

HTG Molecular Diagnostics Inc ( NASDAQ )

Price: $2.81
Change: -0.39 (12.19%)
Volume: 132.9 K
3:59PM ET 1/27/2022

Bio Path Holdings Inc ( NASDAQ )

Price: $3.37
Change: -0.05 (1.46%)
Volume: 26.8 K
3:59PM ET 1/27/2022

Diffusion Pharmaceuticals Inc ( NASDAQ )

Price: $0.24
Change: -0.01 (3.96%)
Volume: 658.0 K
3:56PM ET 1/27/2022

Soligenix Inc ( NASDAQ )

Price: $0.61
Change: -0.004 (0.61%)
Volume: 151.1 K
3:59PM ET 1/27/2022

Read more news Recent News

Top Midday Gainers
1:40PM ET 1/18/2022 MT Newswires

Brickell Biotech (BBI) shares were up 68% to $0.35 Tuesday afternoon after HC Wainwright initiated coverage of the dermatology treatment developer's stock...

--HC Wainwright Starts Brickell Biotech at Buy With $2 Price Target
8:25AM ET 1/18/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Top Premarket Gainers
8:04AM ET 1/18/2022 MT Newswires

Brickell Biotech (BBI) shares surged 39% after the company said in an 8-K filing it has secured an extension to regain its compliance with Nasdaq's listing...

-- Earnings Flash (BBI) BRICKELL BIOTECH Reports Q3 Revenue $0.1M, vs. Street Est of $0.15M
4:20PM ET 11/09/2021 MT Newswires


Company Profile

Business DescriptionBrickell Biotech, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO. View company web site for more details
Address5777 Central Avenue
Boulder, Colorado 80301
Number of Employees30
Recent SEC Filing12/14/20218-K
Chief Executive Officer & DirectorRobert B. Brown
Chief Operating Officer & SecretaryAndrew D. Sklawer
Chief Financial OfficerAlbert N. Marchio
Chief Research & Development OfficerDeepak Chadha

Company Highlights

Price Open$0.21
Previous Close$0.21
52 Week Range$0.20 - 1.70
Market Capitalization$23.6 M
Shares Outstanding115.0 M
SectorHealth Technology
IndustryPharmaceuticals: Major
Next Earnings Announcement03/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.62
Beta vs. S&P 500N/A
Revenue$1.6 M
Net Profit Margin-12,468.50%
Return on Equity-165.40%

Analyst Ratings as of 01/14/2022

Consensus RecommendationConsensus Icon
Powered by Factset